Mira Katan, MD is an expert in Neurology at University Hospital of Basel (Switzerland). As of October 2026, ScienceLeadR ranks Mira Katan in the top 1% of experts worldwide for Cerebrovascular Disorders. Mira Katan has authored 192 publications, the most recent in 2026, and is an investigator in 18 clinical trials, 5 of them ongoing. SLR score: 905 (community average: 125). How the SLR is computed.

LeadR Profile

Mira Katan, MD University Hospital of Basel Switzerland
905 ScienceLeadR Reputation 905
Network Map

Neurology

Subspecialties: Cardiology - Public Health

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2004 - 2026

Source: PubMed

University Hospital of Basel

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 192

Citations

Citations: 6 136 1st author: 20 Last author: 40 Unique author: 0


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Size and location of intracranial hemorrhage in acute stroke presentations: correlation with baseline NIHSS and relevance to direct-to-angiography workflows.
PMID 42774128 — epidemiology, hemorrhage, stroke, workflow, intracranial hemorrhages, angiography, brain stem
Front Neurol20260
Carotid Artery Stenting vs Endarterectomy Across Procedural Eras : A Systematic Review and Meta-Analysis.
PMID 42704462 — stents, safety, stroke, myocardial infarction, carotid arteries, cranial nerve injuries, cranial nerves, arteries, diagnostic imaging, therapeutics, endarterectomy
Clin Neuroradiol20260
Serum Lipoprotein(a) and Hemorrhagic Stroke Risk: A Systematic Review and Meta-Analysis.
PMID 42617990 — cerebral hemorrhage, hemorrhage, ischemic stroke, serum, stroke, lipoproteins, case-control studies, hemorrhagic stroke, cohort studies, subarachnoid hemorrhage, cerebrovascular disorders, lipoprotein(a)
J Stroke Cerebrovasc Dis20260
Current practices in delirium prevention and treatment after acute stroke: results of a multicentre survey.
PMID 42591874 — nurses, delirium, stroke, physicians, therapeutics, workforce
Ther Adv Neurol Disord20260
Effect of anaesthesia modality on outcome in medium or distal vessel occlusion stroke: a post-hoc analysis of the DISTAL trial.
PMID 42566703 — anesthesia, stroke, therapeutics
Eur Stroke J20260

Clinical Studies 18

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 3

By phase:

N/A 14
Phase 3 3
Phase 4 1

By status:

Completed 9
Recruiting 6
Active not recruiting 2
Unknown 1

By type:

Observational 10
Interventional 8

By Monocentric/Multicentric:

monocentric 4
multicentric2to4 4
multicentric5to9 3
multicentricup10 7

Main Topics

Cohort/Consortium Investigators 3

Ongoing Clinical Trials

5 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Safety and Efficacy of Intravenous Thrombolysis in Patients With Ischemic Stroke and Direct Oral Anticoagulants Intake
NCT06571149 — anticoagulants, safety, ischemic stroke, stroke, plasminogen, plasminogen activators, tissue plasminogen activator, rivaroxaban, tenecteplase, therapeutics, tissues, dabigatran, direct-acting oral anticoagulants, apixaban, edoxaban
Phase 4Recruiting2025
PeRforation EVents During ENdovascular Therapy for Acute Ischemic Stroke
NCT06394180 — registries, ischemic stroke, stroke, hemostatics, therapeutics, thrombectomy
N/ARecruiting2024
Discovery of New Cancer in the 1 year Follow up After Ischemic Stroke in Patients at Risk The INVISIBLE 1 Study
NCT06100718 — ischemic stroke, stroke, incidence, neoplasms, therapeutics, cerebral infarction, embolic stroke, ischemia, embolic stroke of undetermined source
N/ARecruiting2022
Early Closure of Left Atrial Appendage for Patients With Atrial Fibrillation and Ischemic Stroke Despite Anticoagulation Therapy
NCT05976685 — anticoagulants, atrial appendage, embolism, ischemic stroke, stroke, atrial fibrillation, physicians, therapeutics, direct-acting oral anticoagulants
N/ARecruiting2024
EnDovascular Therapy Plus Best Medical Treatment (BMT) Versus BMT Alone for MedIum VeSsel Occlusion sTroke
NCT05029414 — stents, blood, ischemic stroke, stroke, brain, quality-adjusted life years, therapeutics, thrombosis, catheters
N/ARecruiting2021

LeadR Networks

Main global connection map